These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 112027)

  • 1. Cost-effective clinical applications are thrust of its report to Congress.
    Hosp Pract; 1979 Mar; 14(3):29, 35, 44-6 passim. PubMed ID: 112027
    [No Abstract]   [Full Text] [Related]  

  • 2. Meeting Report: AGA Biosimilars Roundtable.
    Howden CW; Lichtenstein GR
    Gastroenterology; 2018 Apr; 154(5):e1-e5. PubMed ID: 29510132
    [No Abstract]   [Full Text] [Related]  

  • 3. Report to Congress on rising cost of Social Security Disability Insurance benefits.
    Soc Secur Bull; 1996; 59(1):67-71. PubMed ID: 8799963
    [No Abstract]   [Full Text] [Related]  

  • 4. A report to the Congress on digestive diseases.
    Jacobson ED
    Hosp Pract; 1979 Apr; 14(4):11, 17, 23. PubMed ID: 437748
    [No Abstract]   [Full Text] [Related]  

  • 5. The economic consequences of NSAID-induced gastrointestinal damage.
    de Pouvourville G; Tasch RF
    Eur J Rheumatol Inflamm; 1993; 13(1):33-40. PubMed ID: 7821337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional disorders of the gastrointestinal tract: Cost effectiveness review.
    Mapel DW
    Best Pract Res Clin Gastroenterol; 2013 Dec; 27(6):913-31. PubMed ID: 24182611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost benefit and cost containment.
    Jacobs WH
    Gastrointest Endosc; 1982 May; 28(2):110-1. PubMed ID: 6806141
    [No Abstract]   [Full Text] [Related]  

  • 8. [Trends in visceral surgery--functional, reconstructive, cost-effective].
    Schlumpf R
    Schweiz Med Wochenschr; 1998 Jan; 128(1-2):23-5. PubMed ID: 9491465
    [No Abstract]   [Full Text] [Related]  

  • 9. Inflammatory bowel disease-attributable costs and cost-effective strategies in the United States: a review.
    Park KT; Bass D
    Inflamm Bowel Dis; 2011 Jul; 17(7):1603-9. PubMed ID: 21053357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cost-benefit analysis in gastroenterology. Has the time come?].
    Birkner B
    Leber Magen Darm; 1992 Nov; 22(6):207-8. PubMed ID: 1479864
    [No Abstract]   [Full Text] [Related]  

  • 11. Cost-effectiveness and Decision Analysis in Clinical Gastroenterology and Hepatology: From Evidence to Informed Decision Making.
    Chhatwal J; Kanwal F
    Clin Gastroenterol Hepatol; 2018 Apr; 16(4):459-461. PubMed ID: 29246695
    [No Abstract]   [Full Text] [Related]  

  • 12. The cost of knowing the truth-limitations to a cost-benefit analysis of upper GI endoscopy.
    Sonnenberg A; Blum AL
    J Clin Gastroenterol; 1982 Apr; 4(2):109-14. PubMed ID: 6806350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PanAmerican Congress of Gastroenterology.
    Bond JH
    Gastrointest Endosc; 1998 May; 47(5):433. PubMed ID: 9609450
    [No Abstract]   [Full Text] [Related]  

  • 14. Cost benefit analysis is not cost effective.
    O'Donnell MP
    Am J Health Promot; 1988; 3(1):74-5. PubMed ID: 10312596
    [No Abstract]   [Full Text] [Related]  

  • 15. New Congress poses challenges for advocates. Key changes in Congress could have impact.
    AIDS Alert; 2005 Jan; 20(1):8-9. PubMed ID: 15717356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is the use of COX-2 inhibitors in gastroenterology cost-effective?
    Graham DY; Chan FK
    Nat Clin Pract Gastroenterol Hepatol; 2004 Dec; 1(2):60-1. PubMed ID: 16265047
    [No Abstract]   [Full Text] [Related]  

  • 17. Cost-effectiveness studies: are they always cost effective?
    Kozma CM
    Manag Care Interface; 1999 Nov; 12(11):64-5. PubMed ID: 11184272
    [No Abstract]   [Full Text] [Related]  

  • 18. The increasing need for health-economic assessment in gastrointestinal and liver diseases.
    Bardou M; Martin J
    Best Pract Res Clin Gastroenterol; 2013 Dec; 27(6):829-30. PubMed ID: 24182603
    [No Abstract]   [Full Text] [Related]  

  • 19. Closing the doughnut hole: no easy answers.
    Danzon PM
    Health Aff (Millwood); 2004; Suppl Web Exclusives():W4-405-8. PubMed ID: 15451952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cost-effectiveness of misoprostol prevention].
    Larsson PO
    Lakartidningen; 1992 Oct; 89(44):3657. PubMed ID: 1460977
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.